Clinical Trial Update: Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23)

View source ↗

Summary

Clinical trial protocol update for Access Anti-HAV and Access Anti-HAV IgM assays in Europe (HAV-EU-11-23) sponsored by Beckman Coulter; the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Access Anti-HAV (Hepatitis A Virus Antibody Assay)
• Access Anti-HAV IgM (Hepatitis A Virus IgM Antibody Assay)

Snippet

Sponsor: Beckman Coulter, Inc. | Conditions: HAV | Status: COMPLETED